Los Angeles Capital Management’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$345K Sell
4,700
-44,604
-90% -$3.27M ﹤0.01% 1001
2025
Q1
$5.63M Buy
49,304
+22,791
+86% +$2.6M 0.02% 276
2024
Q4
$1.34M Hold
26,513
0.01% 543
2024
Q3
$1.23M Hold
26,513
0.01% 581
2024
Q2
$861K Sell
26,513
-22,306
-46% -$725K ﹤0.01% 699
2024
Q1
$1.23M Sell
48,819
-1,400
-3% -$35.3K ﹤0.01% 630
2023
Q4
$1.63M Sell
50,219
-9,072
-15% -$295K 0.01% 522
2023
Q3
$1.62M Buy
59,291
+47,359
+397% +$1.29M 0.01% 503
2023
Q2
$265K Buy
11,932
+2,037
+21% +$45.3K ﹤0.01% 1042
2023
Q1
$214K Sell
9,895
-48,101
-83% -$1.04M ﹤0.01% 1109
2022
Q4
$1.18M Sell
57,996
-5,000
-8% -$102K 0.01% 654
2022
Q3
$1.62M Buy
62,996
+29,214
+86% +$749K 0.01% 556
2022
Q2
$803K Buy
33,782
+20,360
+152% +$484K ﹤0.01% 799
2022
Q1
$302K Buy
+13,422
New +$302K ﹤0.01% 1234
2021
Q2
Sell
-8,615
Closed -$205K 1555
2021
Q1
$205K Sell
8,615
-6,585
-43% -$157K ﹤0.01% 1535
2020
Q4
$398K Sell
15,200
-15,620
-51% -$409K ﹤0.01% 1287
2020
Q3
$536K Sell
30,820
-7,510
-20% -$131K ﹤0.01% 1053
2020
Q2
$645K Buy
38,330
+20,600
+116% +$347K ﹤0.01% 1013
2020
Q1
$211K Buy
17,730
+2,830
+19% +$33.7K ﹤0.01% 1158
2019
Q4
$180K Buy
+14,900
New +$180K ﹤0.01% 1214
2019
Q1
Sell
-12,893
Closed -$172K 1368
2018
Q4
$172K Sell
12,893
-95,994
-88% -$1.28M ﹤0.01% 1215
2018
Q3
$1.53M Buy
108,887
+49,345
+83% +$692K 0.01% 742
2018
Q2
$936K Sell
59,542
-17,340
-23% -$273K 0.01% 924
2018
Q1
$1.27M Sell
76,882
-72,960
-49% -$1.2M 0.01% 759
2017
Q4
$2.71M Buy
149,842
+79,793
+114% +$1.44M 0.01% 583
2017
Q3
$1.35M Buy
70,049
+54,460
+349% +$1.05M 0.01% 720
2017
Q2
$184K Buy
+15,589
New +$184K ﹤0.01% 1158